JSC
TMO icon

Jackson Square Capital’s Thermo Fisher Scientific TMO Stock Holding History

Jackson Square Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.11M Sell
4,215
-322
-7% -$155K 0.29% 51
2026
Q1 		$2.23M Sell
4,537
-74
-2% -$40.2K 0.47% 49
2025
Q4 		$2.67M Buy
4,611
+44
+1% +$24.9K 0.53% 46
2025
Q3 		$2.22M Sell
4,567
-656
-13% -$305K 0.48% 47
2025
Q2 		$2.12M Sell
5,223
-35
-0.7% -$14.6K 0.47% 51
2025
Q1 		$2.62M Sell
5,258
-685
-12% -$371K 0.85% 29
2024
Q4 		$3.09M Sell
5,943
-4,367
-42% -$2.4M 0.75% 34
2024
Q3 		$6.38M Buy
10,310
+4,268
+71% +$2.53M 1.58% 18
2024
Q2 		$3.34M Sell
6,042
-39
-0.6% -$22.3K 0.82% 34
2024
Q1 		$3.53M Buy
6,081
+43
+0.7% +$24.1K 0.91% 36
2023
Q4 		$3.2M Sell
6,038
-4,394
-42% -$2.13M 1.03% 29
2023
Q3 		$5.28M Buy
10,432
+222
+2% +$118K 2.12% 16
2023
Q2 		$5.33M Sell
10,210
-1,137
-10% -$614K 2.14% 14
2023
Q1 		$6.54M Sell
11,347
-22
-0.2% -$12.4K 2.93% 6
2022
Q4 		$6.26M Sell
11,369
-326
-3% -$173K 2.95% 5
2022
Q3 		$5.93M Sell
11,695
-12
-0.1% -$6.72K 2.89% 6
2022
Q2 		$6.36M Buy
11,707
+170
+1% +$93.6K 2.69% 6
2022
Q1 		$6.81M Buy
11,537
+188
+2% +$108K 2.13% 11
2021
Q4 		$7.57M Buy
11,349
+239
+2% +$149K 2.18% 9
2021
Q3 		$6.35M Sell
11,110
-2
-0% -$1.1K 2.06% 8
2021
Q2 		$5.61M Sell
11,112
-207
-2% -$97.7K 1.8% 12
2021
Q1 		$5.17M Sell
11,319
-336
-3% -$160K 1.97% 9
2020
Q4 		$5.43M Buy
11,655
+271
+2% +$127K 2.09% 11
2020
Q3 		$5.03M Buy
11,384
+1,711
+18% +$707K 2.21% 7
2020
Q2 		$3.5M Buy
9,673
+433
+5% +$145K 1.77% 19
2020
Q1 		$2.62M Sell
9,240
-1,260
-12% -$397K 2.04% 14
2019
Q4 		$3.41M Buy
+10,500
New +$3.18M 1.97% 10

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jackson Square Capital's TMO Position: Q2 2026 in Review

Jackson Square Capital reduced its Thermo Fisher Scientific (TMO) stake by 7.1% in Q2 2026, selling an estimated $155K and leaving 4,215 shares worth $2.11M. The position accounts for 0.29% of the portfolio, ranked #51.

Jackson Square Capital first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. The position peaked at $7.57M in Q4 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Jackson Square Capital held 4,215 shares of Thermo Fisher Scientific worth $2.11M as of Q2 2026.
  • Jackson Square Capital sold 322 Thermo Fisher Scientific shares in Q2 2026, an estimated $155K.
  • Thermo Fisher Scientific made up 0.29% of Jackson Square Capital's portfolio in Q2 2026, its #51 holding.
  • Jackson Square Capital first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • Jackson Square Capital's Thermo Fisher Scientific position peaked at $7.57M in Q4 2021.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Jackson Square Capital's 13F filing for Q2 2026, filed 21 Jul 2026.